Serine or cysteine protease inhibitor
| GO Term |
|---|
| extracellular space |
| endoplasmic reticulum |
| GO Term |
|---|
| negative regulation of peptidase activity |
| GO Term |
|---|
| serine-type endopeptidase inhibitor activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 63 |
|
|
||
| 82 |
|
|
||
| 184 |
|
|
| Pathway Name | Organism |
|---|---|
| COPII-mediated vesicle transport | Caenorhabditis elegans |
| Cargo concentration in the ER | Caenorhabditis elegans |
| Common Pathway of Fibrin Clot Formation | Caenorhabditis elegans |
| Dissolution of Fibrin Clot | Caenorhabditis elegans |
| G alpha (i) signalling events | Caenorhabditis elegans |
| G alpha (q) signalling events | Caenorhabditis elegans |
| Glucocorticoid biosynthesis | Caenorhabditis elegans |
| Intrinsic Pathway of Fibrin Clot Formation | Caenorhabditis elegans |
| Metabolism of Angiotensinogen to Angiotensins | Caenorhabditis elegans |
| Neutrophil degranulation | Caenorhabditis elegans |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025